About
AI-based Drug Discovery
Areas of Focus
Categories
AI FocusedNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
413
By Phase
PHASE2: 3PHASE1: 1
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04358432Collaborator
A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia
PHASE2Completed
262 participants
Started: May 13, 2020 · Completed: Feb 25, 2021
NCT04173793Collaborator
A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
PHASE2Completed
109 participants
Started: Nov 18, 2019 · Completed: Sep 26, 2022
NCT03933293Collaborator
A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH
PHASE2Completed
10 participants
Started: May 13, 2019 · Completed: Mar 15, 2021
NCT04169386Collaborator
A Study of PCSK9 Inhibitor AK102 in Healthy Subjects
PHASE1Completed
32 participants
Started: May 23, 2018 · Completed: Nov 22, 2018
Locations (1)
Headquarters
Southeastern, PA, United States
Map
Loading map...